US Patent Issued to HANMI PHARM. on April 15 for "Lyophilized formulation of long-acting human growth hormone immunoglobulin conjugate" (South Korean Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,750, issued on April 15, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Lyophilized formulation of long-acting human growth hormone immunoglobulin conjugate" was invented by Hwa Peoung Rim (Seoul, South Korea), Hyun Uk Kim (Busan, South Korea), Ho Taek Im (Yongin-si, South Korea), Sang Yun Kim (Gimpo-si, South Korea), Hyung Kyu Lim (Hwaseong-si, South Korea), Sung Min Bae (Seongnam-si, South Korea) and Se Chang Kwon (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A sustained release preparation of a human growth hormone conjugate is disclosed. The sustained release preparation contains a sustained release human ...